Partners

Catalent

Catalent is a global CDMO supporting GS010/LUMEVOQ® manufacturing, including process transfer and the operational readiness needed to reliably supply clinical and regulatory programs.

15-20 National Hospital (Paris)

CHNO des Quinze-Vingts is a leading ophthalmology hospital that has played a crucial role in patient access and treatment delivery for GS010, helping translate GenSight Biologics’ gene therapy into real-world clinical care.

Institut de la Vision (Paris)

Institut de la Vision is a world-class center for vision science and a natural partner for GenSight Biologics, contributing deep ophthalmology expertise that supports work across retinal disease and vision restoration.

Friedrich Miescher Institute (FMI)

The Friedrich Miescher Institute is a high-caliber research institute collaborating on scientific work relevant to GenSight Biologics’ pipeline and the evolution of its technology platforms.

Inserm Transfert

Inserm Transfert provides access to key intellectual property underpinning GS010, helping secure the rights needed to advance development and, ultimately, commercialization.

UPMC

UPMC participates in the same scientific-data licensing framework, supporting GS010 related development work through access to relevant data assets.

University of Alberta

The University of Alberta is a co-holder of patent rights referenced in the GS030 context, complementing the MIT licensing framework that supports the platform’s scientific foundations.

Sight Again Program

The Sight Again Program is a collaborative framework designed to accelerate vision restoration innovations by aligning complementary technologies, partners and resources around a shared objective.

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France